A major advance in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This vital cancer inhibitor protein is frequently disabled in various kinds of malignancies, resulting uncontrolled https://royalbookmarking.com/story21913762/nanobodies-restore-tumor-suppressor-p53-a-promising-approach-for-cancer-treatment